Listed by the USPTO as HALVORSON, MARK
Tech Center 1600 • Art Units: 1600 1623 1642 1646
This examiner grants 48% of resolved cases
Mark Halvorson is an examiner in Art Unit 1600 of Tech Center 1600. The examiner has 814 resolved cases and an allowance rate of 47.9%. The median time to allowance is 1325 days. This 47.9% rate suggests a more challenging prosecution environment than some other units.
The interview lift is 20.7%, indicating that interviews are a productive strategy for increasing the 47.9% probability of allowance. Top companies include President and Fellows of Harvard College, Regeneron Pharmaceuticals Inc., and Genentech Inc. These major research and biotech entities are often represented by firms such as BANNER & WITCOFF, LTD., BakerHostetler, and BALLARD SPAHR LLP.
The 1325 days median pendency is a key metric for managing expectations in this art unit. With 814 resolved cases, the examiner's data is statistically significant. Practitioners should use the 20.7% interview lift as a strategic tool to navigate the 47.9% base allowance rate and improve their chances of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17910637 | A Combined Inhibition of EGFR and NRF2 in The Treatment of Malignant Glioma | Final Rejection | United States Government as represented by the Department of Veterans Affairs |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy47.9% of resolved applications examined by Mark Halvorson were allowed (814 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +20.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Mark Halvorson took 1,325 days on average from filing to allowance.
Mark Halvorson examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
